Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection

Academic labs supporting COVID‐19 diagnostics

(2021) Marc Veldhoen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

(2021) Jennifer M. Dan et al.   SCIENCE

Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies

(2021) Kayoko Shioda et al.   EPIDEMIOLOGY

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Controlling the pandemic during the SARS-CoV-2 vaccination rollout

(2021) João Viana et al.   Nature Communications

SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands

(2021) Maria Skaalum Petersen et al.   Open Forum Infectious Diseases

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset

(2020) Bin Lou et al.   EUROPEAN RESPIRATORY JOURNAL

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

SARS-CoV-2 (COVID-19) by the numbers

(2020) Yinon M Bar-On et al.   eLife

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

(2020) Nina Le Bert et al.   NATURE

Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset

(2020) Patrícia Figueiredo‐Campos et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity.

(2020) Tyler J. Ripperger et al.   IMMUNITY

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

(2020) Mark Ainsworth et al.   LANCET INFECTIOUS DISEASES

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

(2020) Anita S. Iyer et al.   Science Immunology

Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study

(2020) Roberto Pastor-Barriuso et al.   BMJ-British Medical Journal

Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients

(2011) Lifeng Liu et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES